Raj Kishore, PhD, Professor of Pharmacology and Medicine and Director of the Stem Cell Therapy Program in the Center for Translational Medicine at the Lewis Katz School of Medicine at Temple University (LKSOM), and Mohsin Khan, PhD, Assistant Professor of Physiology at the Center for Metabolic Disease Research at LKSOM, served as senior investigators on a study that was published in the print edition of the journal Circulation Research. The research by LKSOM scientists showed that a very small RNA molecule known as miR-294, when introduced into heart cells, can reactivate heart cell proliferation and improve heart function in mice that have had the equivalent of a heart attack in humans. Genetic Engineering & Biotechnology News, News-Medical.net, Medical Xpress, Scienmag, Bioengineer.org, and other outlets provided coverage.
Important announcement concerning Temple Health and Keystone First. Our provider agreement with Keystone First is scheduled to end on July 31st. Click the link below to learn about your options for continuing care at Temple Health.
Learn More
800-TEMPLE-MED
Schedule Appointment
SEARCH TEMPLE HEALTH